tiprankstipranks
Trending News
More News >
Hyloris Pharmaceuticals SA (DE:52U)
:52U
Germany Market

Hyloris Pharmaceuticals SA (52U) Income Statement

Compare
6 Followers

Hyloris Pharmaceuticals SA Income Statement

Last quarter (Q4 2023), Hyloris Pharmaceuticals SA's total revenue was €1.53M, an increase of 125.55% from the same quarter last year. In Q4, Hyloris Pharmaceuticals SA's net income was €-4.37M. See Hyloris Pharmaceuticals SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 2.09M€ 2.95M€ 3.10M€ 175.00K€ 91.00K
Gross Profit
€ 1.99M€ 2.86M€ 2.99M€ 30.00K€ 25.00K
Operating Expenses
€ 17.99M€ 13.37M€ 13.34M€ 5.61M€ 5.30M
Depreciation and Amortization
€ 348.00K€ 196.00K€ 114.00K€ 101.00K€ 103.00K
EBITDA
€ -14.98M€ -11.43M€ -10.78M€ -6.17M€ -5.26M
Operating Income
€ -15.99M€ -10.51M€ -10.35M€ -5.58M€ -5.27M
Other Income/Expenses
€ 613.00K€ -263.00K€ -741.00K€ -119.00K€ -508.00K
Pretax Income
€ -15.38M€ -10.77M€ -11.28M€ -7.14M€ -5.78M
Net Income
€ -15.38M€ -10.77M€ -11.58M€ -7.15M€ -5.77M
Per Share Metrics
Basic EPS
€ -0.55€ -0.40€ -0.45€ -0.28€ -1.15
Diluted EPS
€ -0.55€ -0.40€ -0.45€ -0.28€ -1.15
Weighted Average Shares Outstanding
28.00M 27.20M 25.83M 25.83M 5.00M
Weighted Average Shares Outstanding (Diluted)
28.00M 27.20M 25.83M 25.83M 5.00M
Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis